{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:45:07Z","timestamp":1793832307252,"version":"4.6.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Metformin-associated lactic acidosis (MALA) is a rare but potentially life-threatening complication of metformin therapy, often associated with acute kidney injury (AKI). Sustained low-efficiency dialysis (SLED) offers both haemodynamic stability and effective metformin clearance. However, during regional citrate anticoagulation (RCA), concerns may arise regarding citrate accumulation due to metformin-induced impairment of cellular metabolism. This study assesses the efficacy and safety of SLED with RCA in the management of MALA, providing direct measurements of serum metformin and citrate levels to evaluate drug clearance and potential citrate accumulation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective observational study was conducted on consecutive critically ill patients with severe AKI and suspected MALA undergoing a 16-h SLED session with RCA. Demographic, clinical and laboratory data were collected. Serum metformin and citrate levels were measured via high-performance liquid chromatography and enzymatic spectrophotometric analysis, respectively. Mixed effects linear models were used to analyse serum metformin, lactate, citrate, electrolytes and acid\u2013base parameters over time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-three patients (median age 79\u00a0years; APACHE II score 29) had metformin levels at intensive care unit (ICU) admission above the therapeutic range (median 29.1\u00a0mg\/l; normal: 0.5\u20133). ICU mortality was 22% (n\u00a0=\u00a05). SLED led to significant haemodynamic and acid\u2013base improvements, with a marked reduction in serum lactate. Metformin levels decreased from 27.75\u00a0mg\/l at SLED start to 3.95\u00a0mg\/l, with minimal rebound. Four SLED sessions (17%) were interrupted, with one being due to impending circuit clotting. No biochemical or clinical signs of citrate accumulation were observed, with serum citrate levels consistently &amp;lt;0.5\u00a0mmol\/l. No significant correlation was found between serum metformin and citrate levels or between lactate and citrate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>SLED with RCA is safe and effective in patients with MALA, ensuring adequate KRT duration, rapid metformin clearance and acid\u2013base status restoration. Direct citrate measurements confirmed the absence of accumulation, reinforcing RCA as a viable anticoagulation strategy in this clinical setting.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfaf286","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:32:19Z","timestamp":1760002339000},"source":"Crossref","is-referenced-by-count":2,"title":["Regional citrate anticoagulation ensures safe and effective kidney replacement therapy in metformin-associated lactic acidosis"],"prefix":"10.1093","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5496-4989","authenticated-orcid":false,"given":"Francesca","family":"Di Mario","sequence":"first","affiliation":[{"name":"Universit\u00e0\u0300 di Parma UO Nefrologia, Azienda Ospedaliero-Universitaria Parma, Dipartimento di Medicina e Chirurgia, , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Regolisti","sequence":"additional","affiliation":[{"name":"Scuola di Specializzazione in Nefrologia, Universit\u00e0 di Parma , Dipartimento di Medicina e Chirurgia, Parma ,","place":["Italy"]},{"name":"Universit\u00e0 di Parma UO Clinica e Patologia Medica, Azienda Ospedaliero\u2011Universitaria Parma, Dipartimento di Medicina e Chirurgia, , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Pacchiarini","sequence":"additional","affiliation":[{"name":"Universit\u00e0\u0300 di Parma UO Nefrologia, Azienda Ospedaliero-Universitaria Parma, Dipartimento di Medicina e Chirurgia, , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Mord\u00e0","sequence":"additional","affiliation":[{"name":"Universit\u00e0\u0300 di Parma UO Nefrologia, Azienda Ospedaliero-Universitaria Parma, Dipartimento di Medicina e Chirurgia, , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Greco","sequence":"additional","affiliation":[{"name":"Universit\u00e0\u0300 di Parma UO Nefrologia, Azienda Ospedaliero-Universitaria Parma, Dipartimento di Medicina e Chirurgia, , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Maccari","sequence":"additional","affiliation":[{"name":"Universit\u00e0\u0300 di Parma UO Nefrologia, Azienda Ospedaliero-Universitaria Parma, Dipartimento di Medicina e Chirurgia, , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Di Motta","sequence":"additional","affiliation":[{"name":"Universit\u00e0\u0300 di Parma UO Nefrologia, Azienda Ospedaliero-Universitaria Parma, Dipartimento di Medicina e Chirurgia, , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Oliva","sequence":"additional","affiliation":[{"name":"Universit\u00e0\u0300 di Parma UO Nefrologia, Azienda Ospedaliero-Universitaria Parma, Dipartimento di Medicina e Chirurgia, , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Italiano","sequence":"additional","affiliation":[{"name":"Laboratorio di Immunopatologia Renale \u201cLuigi Migone\u201d, Universit\u00e0 degli Studi di Parma , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Coccini","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Toxicology, Pavia Poison Centre \u2013 National Toxicology Information Centre, Toxicology Unit, Istituti Clinici Scientifici Maugeri IRCCS , Pavia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Roda","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Toxicology, Pavia Poison Centre \u2013 National Toxicology Information Centre, Toxicology Unit, Istituti Clinici Scientifici Maugeri IRCCS , Pavia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Fiaccadori","sequence":"additional","affiliation":[{"name":"Universit\u00e0\u0300 di Parma UO Nefrologia, Azienda Ospedaliero-Universitaria Parma, Dipartimento di Medicina e Chirurgia, , Parma ,","place":["Italy"]},{"name":"Scuola di Specializzazione in Nefrologia, Universit\u00e0 di Parma , Dipartimento di Medicina e Chirurgia, Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"2025100905321115800_bib1","doi-asserted-by":"publisher","first-page":"CD002967","DOI":"10.1002\/14651858.CD002967.pub4","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","volume":"2010","author":"Salpeter","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2025100905321115800_bib2","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.4239\/wjd.v15.i6.1178","article-title":"Metformin-associated lactic acidosis: a mini review of pathophysiology, diagnosis and management in critically ill patients","volume":"15","author":"See","year":"2024","journal-title":"World J Diabetes"},{"key":"2025100905321115800_bib3","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1097\/CCM.0000000000001002","article-title":"Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the Extracorporeal Treatments in Poisoning Workgroup","volume":"43","author":"Calello","year":"2015","journal-title":"Crit Care Med"},{"issue":"Suppl 1","key":"2025100905321115800_bib4","doi-asserted-by":"publisher","first-page":"S158","DOI":"10.2337\/dc24-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes\u20142024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"2025100905321115800_bib5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","article-title":"Metformin: update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"2025100905321115800_bib6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1177\/0885066618793385","article-title":"Review of biguanide (metformin) toxicity","volume":"34","author":"Wang","year":"2019","journal-title":"J Intensive Care Med"},{"key":"2025100905321115800_bib7","doi-asserted-by":"publisher","first-page":"106114","DOI":"10.1016\/j.phrs.2022.106114","article-title":"Mitochondria as an important target of metformin: the mechanism of action, toxic and side effects, and new therapeutic applications","volume":"177","author":"Feng","year":"2022","journal-title":"Pharmacol Res"},{"key":"2025100905321115800_bib8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1046\/j.1463-1326.2003.00241.x","article-title":"Measurement of metformin concentration in erythrocytes: clinical implications","volume":"5","author":"Lalau","year":"2003","journal-title":"Diabetes Obes Metab"},{"key":"2025100905321115800_bib9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"2025100905321115800_bib10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.amjms.2022.01.026","article-title":"Relationship between metformin use and lactic acidosis in advanced chronic kidney disease: the REMIND-TMU study","volume":"364","author":"Chen","year":"2022","journal-title":"Am J Med Sci"},{"key":"2025100905321115800_bib11","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.kint.2022.08.012","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"102","author":"de Boer","year":"2022","journal-title":"Kidney Int"},{"key":"2025100905321115800_bib12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12882-017-0640-4","article-title":"Serum lactate level and mortality in metformin-associated lactic acidosis requiring renal replacement therapy: a systematic review of case reports and case series","volume":"18","author":"Yeh","year":"2017","journal-title":"BMC Nephrol"},{"key":"2025100905321115800_bib13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/15563650.2023.2196372","article-title":"Expanding the evidence for managing metformin poisoning to support decision-making","volume":"61","author":"Roberts","year":"2023","journal-title":"Clin Toxicol"},{"key":"2025100905321115800_bib14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1053\/j.ajkd.2016.12.010","article-title":"Treatment of metformin intoxication complicated by lactic acidosis and acute kidney injury: the role of prolonged intermittent hemodialysis","volume":"70","author":"Regolisti","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2025100905321115800_bib15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40620-018-00562-2","article-title":"Sustained low-efficiency dialysis for metformin-associated lactic acidosis in patients with acute kidney injury","volume":"32","author":"Greco","year":"2019","journal-title":"J Nephrol"},{"key":"2025100905321115800_bib16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13054-023-04519-1","article-title":"Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials","volume":"27","author":"Zhou","year":"2023","journal-title":"Crit Care"},{"key":"2025100905321115800_bib17","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2020.18618","article-title":"Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial","volume":"324","author":"Zarbock","year":"2020","journal-title":"JAMA"},{"key":"2025100905321115800_bib18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2215\/CJN.01240214","article-title":"Long-term risk of upper gastrointestinal hemorrhage after advanced AKI","volume":"10","author":"Wu","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025100905321115800_bib19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/sdi.12946","article-title":"Continuous renal replacement therapy without anticoagulation in critically ill patients at high risk of bleeding: a systematic review and meta-analysis","volume":"34","author":"Zhang","year":"2021","journal-title":"Semin Dial"},{"key":"2025100905321115800_bib20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/kisup.2012.7","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kidney Disease: Improving Global Outcomes Acute Kidney Injury Work Group","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"2025100905321115800_bib21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s44158-023-00091-w","article-title":"Regional citrate anticoagulation (RCA) in critically ill patients undergoing renal replacement therapy (RRT): expert opinion from the SIAARTI-SIN joint commission","volume":"3","author":"Pistolesi","year":"2023","journal-title":"J Anesth Analg Crit Care"},{"key":"2025100905321115800_bib22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1053\/j.ajkd.2006.07.016","article-title":"Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration","volume":"48","author":"Hetzel","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2025100905321115800_bib23","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.2215\/CJN.00510113","article-title":"Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipment","volume":"8","author":"Fiaccadori","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025100905321115800_bib24","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1093\/ndt\/gfad068","article-title":"Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance","volume":"38","author":"Di Mario","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2025100905321115800_bib25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40620-024-02201-5","article-title":"Sustained low-efficiency dialysis (SLED) with regional citrate anticoagulation (RCA) and new dialysis equipment: a prospective study with serum citrate measurements and electrolyte monitoring","volume":"38","author":"Di Mario","year":"2025","journal-title":"J Nephrol"},{"key":"2025100905321115800_bib26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000528252","article-title":"Metformin\u2019s role in hyperlactatemia and lactic acidosis in ICU patients: a systematic review","volume":"108","author":"Mueller","year":"2023","journal-title":"Pharmacology"},{"key":"2025100905321115800_bib27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"2025100905321115800_bib28","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1111\/dom.12974","article-title":"Metformin-associated lactic acidosis (MALA): moving towards a new paradigm","volume":"19","author":"Lalau","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"2025100905321115800_bib29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2215\/CJN.04350422","article-title":"Continuous KRT: a contemporary review","volume":"18","author":"Teixeira","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025100905321115800_bib30","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.2215\/CJN.01280214","article-title":"Regional citrate anticoagulation for RRTs in critically ill patients with AKI","volume":"9","author":"Morabito","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025100905321115800_bib31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/sdi.12959","article-title":"Anticoagulation strategies in continuous renal replacement therapy","volume":"34","author":"Legrand","year":"2021","journal-title":"Semin Dial"},{"key":"2025100905321115800_bib32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/ckj\/sfac223CrossRef","article-title":"A prospective study on serum citrate levels and clinical correlations in patients receiving regional citrate anticoagulation","volume":"16","author":"To","year":"2023","journal-title":"Clin Kidney J"},{"key":"2025100905321115800_bib33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13054-017-1880-1","article-title":"Complications of regional citrate anticoagulation: accumulation or overload?","volume":"21","author":"Schneider","year":"2017","journal-title":"Crit Care"},{"key":"2025100905321115800_bib34","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3390\/life13051198","article-title":"Regional citrate anticoagulation in continuous renal replacement therapy: is metabolic fear the enemy of logic? A systematic review and meta-analysis of randomised controlled trials","volume-title":"Life (Basel)","author":"Jacobs","year":"2023"},{"key":"2025100905321115800_bib35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/03913988211003586","article-title":"Regional citrate anticoagulation versus low molecular weight heparin for CRRT in hyperlactatemia patients: a retrospective case-control study","volume":"45","author":"Li","year":"2022","journal-title":"Int J Artif Organs"},{"key":"2025100905321115800_bib36","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1097\/CCM.0000000000002501","article-title":"Hyperlactatemia, lactate kinetics and prediction of citrate accumulation in critically ill patients undergoing continuous renal replacement therapy with regional citrate anticoagulation","volume":"45","author":"Khadzhynov","year":"2017","journal-title":"Crit Care Med"},{"key":"2025100905321115800_bib37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.34067\/KID.0005342020","article-title":"Regional citrate anticoagulation protocol for patients with presumed absent citrate metabolism","volume-title":"Kidney360","author":"Szamosfalvi","year":"2020"},{"key":"2025100905321115800_bib38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s13054-015-1066-7","article-title":"Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study","volume":"19","author":"Slowinski","year":"2015","journal-title":"Crit Care"},{"key":"2025100905321115800_bib39","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00134-010-1909-2","article-title":"Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients","volume":"36","author":"Mariano","year":"2010","journal-title":"Intensive Care Med"},{"key":"2025100905321115800_bib40","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1093\/ndt\/gfac159","article-title":"Hypophosphatemia in critically ill patients undergoing sustained low-efficiency dialysis with standard dialysis solutions","volume":"37","author":"Di Mario","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"2025100905321115800_bib41","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s40620-020-00864-4","article-title":"Prevention of hypomagnesemia in critically ill patients with acute kidney injury on continuous kidney replacement therapy: the role of early supplementation and close monitoring","volume":"34","author":"Di Mario","year":"2021","journal-title":"J Nephrol"},{"key":"2025100905321115800_bib42","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/ndt\/gfac210","article-title":"The conundrum of the complex relationship between acute kidney injury and cardiac arrhythmias","volume":"38","author":"Genovesi","year":"2023","journal-title":"Nephrol Dial Transplant"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/10\/sfaf286\/64246974\/sfaf286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/10\/sfaf286\/64246974\/sfaf286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:32:20Z","timestamp":1760002340000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf286\/8251670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf286","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,11]]},"article-number":"sfaf286"}}